Sanofi ADR (NASDAQ: SNY) on Friday, plunged -0.38% from the previous trading day, before settling in for the closing price of $52.34. Within the past 52 weeks, SNY’s price has moved between $44.62 and $60.12.
A company in the Healthcare sector has jumped its sales by 13.05% annually for the last half of the decade. The company achieved an average annual earnings per share of 21.22%. With a float of $2.43 billion, this company’s outstanding shares have now reached $2.61 billion.
Sanofi ADR (SNY) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Sanofi ADR is 0.01%, while institutional ownership is 9.78%.
Sanofi ADR (SNY) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.68 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.74) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.99 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.25% during the next five years compared to 13.05% growth over the previous five years of trading.
Sanofi ADR (NASDAQ: SNY) Trading Performance Indicators
Sanofi ADR (SNY) is currently performing well based on its current performance indicators. A quick ratio of 0.94 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.93. Likewise, its price to free cash flow for the trailing twelve months is 11.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.01, a number that is poised to hit 0.82 in the next quarter and is forecasted to reach 4.90 in one year’s time.
Technical Analysis of Sanofi ADR (SNY)
Let’s dig in a bit further. During the last 5-days, its volume was 1.74 million. That was inferior than the volume of 2.7 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 88.47%.
During the past 100 days, Sanofi ADR’s (SNY) raw stochastic average was set at 93.30%, which indicates a significant increase from 86.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.71 in the past 14 days, which was lower than the 0.72 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.00, while its 200-day Moving Average is $50.99. However, in the short run, Sanofi ADR’s stock first resistance to watch stands at $52.38. Second resistance stands at $52.61. The third major resistance level sits at $52.80. If the price goes on to break the first support level at $51.95, it is likely to go to the next support level at $51.76. The third support level lies at $51.53 if the price breaches the second support level.
Sanofi ADR (NASDAQ: SNY) Key Stats
Market capitalization of the company is 126.89 billion based on 2,455,512K outstanding shares. Right now, sales total 47,922 M and income totals 6,016 M. The company made 15,394 M in profit during its latest quarter, and 3,275 M in sales during its previous quarter.
